Kadimastem Israeli Company
Kadimastem develops industrial regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells to treat diseases such as amyotrophic lateral sclerosis (ALS) and diabetes.
Health Tech & Life Sciences
Biotechnology
Therapeutics
Alternatives
No alternatives listed yet.
Suggest an Alternative
Founders
Parent Companies/Investors
Office Locations
Ness Ziyyona, Israel
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/kadimastem
[2]
crunchbase.com
- https://www.crunchbase.com/organization/kadimastem
External links are provided for reference and verification purposes.